TY  - GEN
AU  - Puri,Raman
AU  - Mehta,Vimal
AU  - Duell,P Barton
AU  - Nair,Devaki
AU  - Mohan,Jagdish Chander
AU  - Yusuf,Jamal
AU  - Dalal,Jamshed J
AU  - Mishra,Sundeep
AU  - Kasliwal,Ravi R
AU  - Agarwal,Rajeev
AU  - Mukhopadhyay,Saibal
AU  - Wardhan,Harsh
AU  - Khanna,Narendra Nath
AU  - Pradhan,Akshaya
AU  - Mehrotra,Rahul
AU  - Kumar,Amit
AU  - Puri,Sonika
AU  - Muruganathan,Arumugam
AU  - Sattur,Gururaj Balvantrao
AU  - Yadav,Madhur
AU  - Singh,Harinder Pal
AU  - Agarwal,Rajesh Kumar
AU  - Nanda,Rashmi
TI  - Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India
SN  - 1933-2874
PY  - 2021///0629
KW  - Antibodies, Monoclonal
KW  - immunology
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Cholesterol, LDL
KW  - blood
KW  - Clinical Trials as Topic
KW  - Consensus
KW  - Goals
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipoproteinemia Type II
KW  - India
KW  - Lipoprotein(a)
KW  - Mutation
KW  - Practice Guidelines as Topic
KW  - Proprotein Convertase 9
KW  - genetics
KW  - Secondary Prevention
KW  - methods
KW  - Social Control, Formal
KW  - Societies, Medical
KW  - Triglycerides
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.jacl.2020.01.006
ER  -